Science in Sport (#SIS) – H1 another loss, notes “amended and extended banking arrangements”

Science in Sport (#SIS) – raises £8m from 17p per share placing

Science in Sport (#SIS) – argues improving performance but still expected increased net debt to £13.8m

Science in Sport – “Trading Update”. Er, what about the 2024 outlook against expectations which dare not speak its name?

There is an announcement, titled “Trading Update”, today from Science in Sport (SIS), but which also has a headline “Fundamental Change in Operating Model and Restructuring of Cost Base”. Hmmm, as is usual, is that because trading isn’t going well?

Science in Sport (#SIS) – 2022 results final auditor sign off “still outstanding”, shares suspended

Science in Sport – emphasises “growth and efficiency plan” and trading momentum “gathering”, but what about cash flow?

‘Performance nutrition company’ Science in Sport (SIS) has announced what it states is “an ambitious growth and efficiency plan”and that on trading “momentum is gathering”. So what of a current share price up to 9p, giving a £15.5 million market capitalisation?

Science in Sport (#SIS) – emphasises a “growth and efficiency plan” and argues trading “momentum is gathering”

Science in Sport (#SIS) – FY revenue +1.5%, argues “optimistic about the prospects for 2023”

Science in Sport (#SIS) – proposed £5m placing at 15p per share ‘to strengthen balance sheet’, to conduct a “strategic review”

Science in Sport (#SIS) – CFO change, appointment of Daniel Lampard currently CFO of Unbound Group (#UBG)

Science in Sport (#SIS) – H1 approx. 12% revenue growth lower than expected and adverse costs

Science In Sport (#SIS) – H1 revenue “£23.6m, down 5% on last year”

Science in Sport – shares bouncing on placing, but...

‘Performance nutrition company’ Science in Sport (SIS) “is pleased to announce the completion of the placing… raising gross proceeds of approximately £4.5 million… at a price of 37 pence per share” – and the shares have currently responded up to around 40p...

Science in Sport – trading update, valuation as well as its nutrition products “premium”?

Self-styled “the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community”, Science in Sport (SIS) has updated commencing “2019 has seen rapid progress at the company… total sales growth for the year to 31 December 2019 is expected to be slightly ahead of market expectations, with sales momentum into 2020 underpinned by operational progress including a new PhD.com e-commerce platform and a new protein powder line, which is now in full production”. Sounds encouraging…

Science in Sport (#SIS) – FY sales growth “expected to be slightly ahead of market expectations” but bottom-line hit by whey price increase & FX

Science in Sport (#SIS) – proposed £32m acquisition of PhD Nutrition Ltd, £29m placing at 60p

Science in Sport (#SIS) – placing and open offer to raise up to £15m at 70p

Science in Sport (#SIS) announces deal with leading British Football club , er Aston Villa? Er...no comment

Science in Sport – a “trading update” which omits to update on the bottom-line impact of trading!

Sports nutrition company Science in Sport (SIS) has made a “Pre-Close Trading Update” announcement commencing that “sales increased 30% to £12.24 million in the 12 months to 31 December 2016”. Sounds promising, what about profitability?…

Science in Sport: Cashed up and ready to go

I tipped Science in Sport (SIS) last month following the announcement of an exciting tie-up with Liverpool FC. This morning sees the release of the company’s interim results, confirming excellent progress made and with good omens for future profitability.